After SECTM1 knockdown, the expression of TGF-β1 and TGFβR2 in GBM cell lines was down-regulated, and the TGF-β1/Smad signaling pathway was inhibited, thus inhibiting the proliferation, migration, invasion and EMT-like process of GBM. The gene discussed is TGFB1; the disease is glioblastoma.